Immediate Impact
3 by Nobel laureates 1 from Science/Nature 76 standout
Citing Papers
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Works of Roberto Arrojo being referenced
Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2 –wild-type Triple-Negative Breast Cancer
2017
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Roberto Arrojo | 300 | 131 | 147 | 11 | 381 | |
| Nancy S. Scher | 270 | 94 | 123 | 8 | 407 | |
| Catherine Copigneaux | 254 | 204 | 118 | 17 | 411 | |
| Nicholas C.L. Wong | 222 | 167 | 161 | 9 | 386 | |
| Laurence Hatteville | 291 | 70 | 90 | 10 | 379 | |
| J Sandle | 180 | 144 | 60 | 15 | 375 | |
| Kaisa Erjala | 216 | 158 | 58 | 8 | 338 | |
| George Horng | 140 | 127 | 91 | 9 | 336 | |
| Yvonne H. W. Derks | 156 | 99 | 188 | 16 | 449 | |
| Manuela Kohler | 172 | 162 | 69 | 11 | 340 | |
| Bruce McCall | 268 | 106 | 95 | 14 | 365 |
All Works
Loading papers...